MacroLensNP नेपालीने Sign in Create accountSign up
Free · Hydropower

VLUCL Vision Lumbini Urja Company Limited

Rs 376.90 +0.90 (+0.24%) as of 2026-11-06 15:00:00
Open
376.00
High
380.00
Low
365.00
Prev. close
376.00
Volume
6,612
Turnover
24.92 lakh
Avg volume (30 d)
8,203
52-week low Rs 360.00
high Rs 652.00 -42.2% from the 52-week high

Vision Lumbini Urja Company Limited (VLUCL) is listed on the Nepal Stock Exchange in the Hydropower sector. Its share price is Rs 376.90 as of 6 November 2026, 42.2% below its 52-week high of Rs 652.00 and 4.7% above its 52-week low of Rs 360.00. It trades at a P/E of 79.7 on earnings per share of Rs 4.73, more expensive than the Hydropower sector's median P/E of 50.9.

VLUCL paid a dividend in 1 of the last 1 fiscal years we track; the latest was 3.68% cash for FY 2082/2083. Promoters hold 80% of the shares and the public 10%; the promoter lock-in ends on 20 December 2026.

Key figures latest report 2082/2083 Q4

Market value
720.82 crore · 7.21 arba
Shares listed
19,125,000
Paid-up capital
191.25 crore · 1.91 arba
EPS (annualised)
Rs 4.73
P/E
79.7
Book value / share
Rs 137.71
P/B
2.74
ROE
3.4%
ROA
1.41%
Dividend yield
0.98%
Net profit (annualised)
9.05 crore
Reserves
72.13 crore
Total assets
642.64 crore · 6.43 arba
Debt to equity
–

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 4.73 +311.5% * 9.05 crore 68.44 crore 3.6%
2082/2083 Q3 -8.28 -366.7% * −15.84 crore 38.93 crore loss
2082/2083 Q2 -7.96 -229.4% * −15.23 crore 35.85 crore loss
2082/2083 Q1 -7.78 -429.3% * −14.87 crore 34.01 crore loss
2081/2082 Q4 -2.24 – −4.28 crore 36.65 crore loss
2081/2082 Q3 3.11 -62.3% 5.94 crore 27.56 crore 2.3%
2081/2082 Q2 6.15 -17.1% 11.77 crore 31.49 crore 4.5%
2081/2082 Q1 2.36 0.0% 4.52 crore 19.11 crore 1.7%

* A loss in this year or the year before: the change is measured against the size of last year's EPS - from -13.14 to -6.13 is +53.3%, the loss per share more than halved. Hover a figure for both years.

Dividends

Fiscal yearBonusCashBook close
2082/2083– 3.68% –

Who owns it

Promoters 80% Public 10%
Public float
1,874,250 shares
Mutual funds hold
0.7% of the float
Promoter lock-in
ends 20 Dec 2026

MacroLens analysis of VLUCL

More on VLUCL on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Hydropower companies

CompanyPriceTodayP/EP/BMarket value
SOHL Solu Hydropower Limited 628.00 +0.05% 56.44.55 6,280 crore · 62.80 arba
UPPER Upper Tamakoshi Hydropower Ltd 194.00 +0.52% 44.44.36 4,109 crore · 41.09 arba
SAHAS Sahas Urja Limited 722.00 +0.98% 24.34.00 3,302 crore · 33.02 arba
CHCL Chilime Hydropower Company Lim... 338.00 +0.06% 44.52.73 3,206 crore · 32.06 arba
BPCL Butwal Power Company Limited 694.00 -1.70% 70.53.29 2,366 crore · 23.66 arba
API Api Power Company Ltd. 333.70 +0.21% 22.22.79 2,129 crore · 21.29 arba
MEN Mountain Energy Nepal Limited 567.00 +0.35% 22.23.76 2,125 crore · 21.25 arba
SHPC Sanima Mai Hydropower Ltd. 558.30 +0.96% 71.14.06 2,087 crore · 20.87 arba

Every Hydropower company 112

Browse all NEPSE stocks by sector →

VLUCL: common questions

What is the share price of VLUCL today?

VLUCL (Vision Lumbini Urja Company Limited) closed at Rs 376.90 as of 6 November 2026 on NEPSE.

Does VLUCL pay dividends?

VLUCL paid a dividend in 1 of the last 1 fiscal years we track; the latest was 3.68% cash for FY 2082/2083.

What is the P/E ratio of VLUCL?

It trades at a P/E of 79.7 on earnings per share of Rs 4.73, more expensive than the Hydropower sector's median P/E of 50.9.

Is VLUCL a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - VLUCL's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.